SCHEDULE 13G 0002068530 XXXXXXXX LIVE Common Stock, par value $0.001 per share 11/19/2025 0001404281 Eledon Pharmaceuticals, Inc. 28617K101 19800 MacArthur Blvd. Suite 250 Irvine CA 92612 Rule 13d-1(b) Rule 13d-1(c) Coastlands Capital LP b DE 0.00 4203764.00 0.00 4203764.00 4203764.00 N 5.28 IA PN The calculation of the beneficial ownership of the Reporting Persons is based on 79,630,297 shares outstanding as November 13, 2025, as provided by the Issuer to the Reporting Persons. Excludes pre-funded warrants held by the Reporting Persons with a beneficial ownership limitation of 4.99%. Coastlands Capital Partners LP b DE 0.00 4203764.00 0.00 4203764.00 4203764.00 N 5.28 PN The calculation of the beneficial ownership of the Reporting Persons is based on 79,630,297 shares outstanding as November 13, 2025, as provided by the Issuer to the Reporting Persons. Excludes pre-funded warrants held by the Reporting Persons with a beneficial ownership limitation of 4.99%. Coastlands Capital GP LLC b DE 0.00 4203764.00 0.00 4203764.00 4203764.00 N 5.28 OO The calculation of the beneficial ownership of the Reporting Persons is based on 79,630,297 shares outstanding as November 13, 2025, as provided by the Issuer to the Reporting Persons. Excludes pre-funded warrants held by the Reporting Persons with a beneficial ownership limitation of 4.99%. Coastlands Capital LLC b DE 0.00 4203764.00 0.00 4203764.00 4203764.00 N 5.28 HC OO The calculation of the beneficial ownership of the Reporting Persons is based on 79,630,297 shares outstanding as November 13, 2025, as provided by the Issuer to the Reporting Persons. Excludes pre-funded warrants held by the Reporting Persons with a beneficial ownership limitation of 4.99%. Matthew D. Perry b X1 0.00 4762691.00 0.00 4762691.00 4762691.00 N 5.98 HC IN Consists of 4,203,764 shares held directly by Coastlands Capital LP and 558,927 shares held directly by a trust for which Mr. Perry serves as co-trustee. The calculation of the beneficial ownership of the Reporting Persons is based on 79,630,297 shares outstanding as November 13, 2025, as provided by the Issuer to the Reporting Persons. Excludes pre-funded warrants held by the Reporting Persons with a beneficial ownership limitation of 4.99%. Eledon Pharmaceuticals, Inc. 19800 MacArthur Blvd. Suite 250 Irvine, CA, 92612 Coastlands Capital LP, a Delaware limited partnership ("Coastlands") Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership") Coastlands Capital GP LLC, a Delaware limited liability company (the "General Partner") Coastlands Capital LLC, a Delaware limited liability company ("Coastlands GP") Matthew D. Perry Coastlands and the General Partner are the investment adviser and general partner, respectively, of the Partnership. Coastlands GP is the general partner of Coastlands. Mr. Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein. In addition, the filing of this Schedule 13G on behalf of the Partnership should not be construed as an admission that it is, and it disclaims that it is, a beneficial owner, as defined in Rule 13d-3 under the Act, of any Common Stock covered by this Schedule 13G. 601 California Street, Suite 1210, San Francisco, CA 94108 See Item 4 of the cover sheet for each reporting person. N IA HC Coastlands: 4,203,764 Partnership: 4,203,764 General Partner: 4,203,764 Coastlands GP: 4,203,764 Matthew D. Perry: 4,762,691 Coastlands: 5.28% Partnership: 5.28% General Partner: 5.28% Coastlands GP: 5.28% Matthew D. Perry: 5.98% Coastlands: 0 Partnership: 0 General Partner: 0 Coastlands GP: 0 Matthew D. Perry: 0 Coastlands: 4,203,764 Partnership: 4,203,764 General Partner: 4,203,764 Coastlands GP: 4,203,764 Matthew D. Perry: 4,762,691 Coastlands: 0 Partnership: 0 General Partner: 0 Coastlands GP: 0 Matthew D. Perry: 0 Coastlands: 4,203,764 Partnership: 4,203,764 General Partner: 4,203,764 Coastlands GP: 4,203,764 Matthew D. Perry: 4,762,691 Y N The Partnership holds the shares of Common Stock, including shares of Common Stock issuable upon exercise of pre-funded warrants, for the benefit of its investors and has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, shares of Common Stock, including shares of Common Stock issuable upon exercise of pre-funded warrants. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G Coastlands Capital LP /s/ Mark Shamia 11/24/2025 Coastlands Capital Partners LP /s/ Mark Shamia 11/24/2025 Coastlands Capital GP LLC /s/ Mark Shamia 11/24/2025 Coastlands Capital LLC /s/ Mark Shamia 11/24/2025 Matthew D. Perry /s/ Matthew D. Perry 11/24/2025